ILK (β1-integrin-linked protein kinase): A novel immunohistochemical marker for Ewing's sarcoma and primitive neuroectodermal tumour

Virchows Archiv

Volumn 433, Issue 2, 1998, Pages 113-117

  Chung, Doo Hyun ^a   Lee, Jong Im ^b   Kook, Myeong Cherl ^a   Kim, Jeong Ran ^b   Kim, Soon Ha ^a   Choi, Eun Young ^a   Park, Seong Hoe ^a   Song, Hyung Geun ^c  

^a Seoul National University   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

Author keywords

1 integrin linked protein kinase (ILK); Ewing's sarcoma; Polyclonal antibody; Primitive neuroectodermal tumour

Indexed keywords

INTEGRIN; POLYCLONAL ANTIBODY; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; INTEGRIN LINKED KINASE; INTEGRIN-LINKED KINASE; TUMOR MARKER;

ARTICLE; EWING SARCOMA; GENE EXPRESSION; HEART MUSCLE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MEDULLOBLASTOMA; NERVE CELL; NEUROBLASTOMA; NEUROECTODERM; NEUROECTODERM TUMOR; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; ADOLESCENT; ADULT; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; CHILD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; ENZYMOLOGY; FEMALE; MALE; MOUSE; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANIMALS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; NEUROECTODERMAL TUMORS, PRIMITIVE; ORGAN SPECIFICITY; PROTEIN-SERINE-THREONINE KINASES; SARCOMA, EWING'S; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0031595969     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050225     Document Type: Article

References (24)

1. Ambros IM, Ambros PF, Strehll S, et al (1991) MIC2 is a specific marker for Ewing's sarcoma and peripheral neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67:1886-1893
2. Aussel C, Bernard G, Greittmayer J-P, et al (1993) Monoclonal antibodies directed against the E2 protein (MIC2 gene product) induce exposure of phosphatidyl serine at the thymocyte cell surface. Biochemistry 32:10096-10101
3. Bernard G, Zoccola D, Deckert M, et al (1995) The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+CD8+ thymocytes. J Immunol 154:26-32
4. Bernard G, Breittmeyer J-D, Bernard A (1997) Apoptosis of immature thymocytes mediated by E2/CD99. J Immunol 158:2543-2550
5. Brikhius M, Wijnaemdts LCD, von der Lindes JC, et al (1995) Peripheral primitive neuroectoderamal tumor and extra-osseous Ewing's sarcoma; a histologic, immunihistochemical and DNA flow cytometric study. Virchows Arch 425:611-616
6. Carter RLC, AL-Sam SZ, Corbett RP, Clinton S (1990) A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing sarcoma and other round cell tumors in children. Histopathology 16:461-467
7. Dehner LP (1993) Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 17:1-13
8. Delattre O, Zucman J, Plougastel B, et al (1992) Gene fusion with an ETS DNA-binding domain by chromosome translocation in human tumors. Nature 359:162-165
9. Downing JR, Head DR, Parham DM, et al (1993) Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcrip tion polymerase chain reaction. Am J Pathol 143:1294-1300
10. Fellinger EJ, Garin-Chesa P, Su SL, et al (1991) Biochemical and genetic characterization of the HBA 71 Ewing's sarcoma cell surface antigen. Cancer Res 51:336-340
11. Fellinger EJ, Garin-Chesa P, Classer DB, Huvos AG, Rettig WJ (1992) Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone. Am J Surg Pathol 16:746-755
12. Gelin C, Aubrit P, Phalipon A, et al (1989) The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processed, is the MIC2 gene product. EMBO J 8:3253-3259
13. Giovannini M, Biegel JA, Serra M, et al (1994) EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and peripheral neuroectodermal tumors with variant translocations. J Clin Invest 94:489-496
14. Hahn JH, Kim MK, Choi EY, Kim SH, Sohn HW, Ham DI, Chung DH, Kim TJ, Park CK, Park SH (1997) CD99(MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol 159:2250-2258
15. Hannigan GE, Hagestejin CL, Gibbon LF, et al (1996) Regulation of cell adhesion and anchorage-dependent growth by a new β1-Integrin-linked protein kinase. Nature 379:91-96
16. Hara S, Ishii E, Tanaka S, et al (1989) A monoclonal antibody specifically reactive with Ewing's sarcoma. Br J Cancer 60:875-879
17. Jung KC, Kim TJ, CHung DH, et al (1996) An antibody against E2/MIC2 antigen (CD99): identification and characterization. J Korean Cancer Assoc 28:350-357
18. Navarro S, Cavazzana AO, Llombart-Bosch A, Triche TJ (/1994) Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma: an immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasm. Arch Pathol Lab Med 118:608-615
19. Perlman EJ, Dickman PS, Askin FB, et al (1994) Ewing's sarcoma - Routine diagnostic utilization of MIC2 analysis: a pediatric oncology group/children's cancer group intergroup study. Hum Pathol 25:304-307
20. Ramani P, Rampling D, Link M (1993) Immunocytochemical study of 12E7 in small round-cell tumors of childhood: an assessment of its sensitivity and specificity. Histopathology 23:557-561
21. Schmidt D, Herrmann C, Jurgens H, Harm D (1991) Malignant peripheral neuroectodermal tumor and is necessary distinction from Ewing's sarcoma. Cancer 68:2251-2259
22. Scotland K, Serra M, Cristina Manara M, et al (1996) Immunostaining of the p30/32mic2 antigen and molecular detection of Ews rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor. Hum Pathol 27:408-416
23. Sorensen PHB, Lessnick SL, Lopez-Terrada D, et al (1994) A second Ewing's sarcoma translocation, t(21:22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6:146-151
24. Sukimoto T, Umezawa A, Hara J (1997) Neurogenic potential of Ewing's sarcoma cells. Virchows Arch 430:41-136